Get the Stockscreener App
11.25
0.91%
0.101
After Hours:
11.25
Global X Genomics Biotechnology Etf stock is traded at $11.25, with a volume of 25,806.
It is up +0.91% in the last 24 hours and down -1.14% over the past month.
See More
Previous Close:
$11.15
Open:
$11.14
24h Volume:
25,806
Relative Volume:
0.49
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.72%
1M Performance:
-1.14%
6M Performance:
-1.14%
1Y Performance:
+10.62%
1-Day Range:
$11.13
$11.29
1-Week Range:
$10.84
$11.29
52-Week Range:
$8.63
$12.53
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Name
Global X Genomics Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Global X Genomics Biotechnology Etf Stock (GNOM) Latest News
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
How To Avoid The Worst Sector ETFs 3Q24 - Forbes
Investing in Nobel Prize Achievements – CRISPR For Precise Genetic Engineering - Securities.io
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
(GNOM) Proactive Strategies - Stock Traders Daily
3 Gene Editing Stocks with Potential to Transform Medicine - InvestorPlace
BioTech & Genomics ETFs Shine Amid Sector Rotation - Trackinsight
Time for Healthcare ETFs? - Yahoo Finance
Biotech ETFs See Uptick Amid Positive Market Signs - Trackinsight
The 3 Best Gene Editing Stocks to Buy in July 2024 - InvestorPlace
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
7 Best Biotech ETFs to Buy Now | Investing - U.S News & World Report Money
How To Trade (GNOM) - Stock Traders Daily
Top Sector ETFs From Wall Street's Best Week in 3 Months - Yahoo New Zealand News
Why this money manager is shoring up cash and buying into commodities, genomics and Mexico - The Globe and Mail
5 Small-cap Biotech ETFs to Watch (Updated 2024) | INN - Investing News Network
When the Price of (GNOM) Talks, People Listen - Stock Traders Daily
Where are the Opportunities in (GNOM) - Stock Traders Daily
Private Advisor Group LLC Lowers Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
9 Best Biotech ETFs for 2024 - MSN
Beyond Ordinary Model Portfolios - Global X
Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Rises By 69.1% - Defense World
Profit from the Genomics Market Momentum With These ETFs - Yahoo Movies UK
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life - InvestorPlace
Genomics ETF (GNOM) Hits New 52-Week High - Yahoo Lifestyle UK
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire - InvestorPlace
(GNOM) Technical Data - Stock Traders Daily
In the Pipeline: Top Drug Candidates for FDA Approval in 2024 - Nasdaq
The Next Big Theme: April 2024 - Global X
9 Best Biotech ETFs for 2024 - GOBankingRates
Global X ETFs Announces Expansion into French Market with Five ETFs - RankiaPro En
Investing in Pharma: How to Spot Leading Drug Candidates - Global X
CTNM Stock: Discover Biotech Investing Potential with Contineum Therapeutics - Value the Markets
Genomics and the Future of Healthcare Diagnostics – Global X ETFs - Global X
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment (NASDAQ:GNOM) - Seeking Alpha
3 Stocks That Could Be the Next Big Thing in Gene Editing - InvestorPlace
The Next Big Theme: March 2024 - Global X
Why Gene Editing Could Be Worth $120 Billion by 2027 - Opto RoW
Biotech Funds Underperform the Broader Market - Trackinsight
Video: Give Someone a Fish, You Feed Them—Unlock the Fish - CSRwire.com
Gene Therapy: A Cure for Cancer? - Opto RoW
Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 ... - Nature.com
The Next Big Theme: February 2024 – Global X ETFs - Global X
Genomic data in the All of Us Research Program - Nature.com
In the Pipeline: Top Drug Candidates for FDA Approval in 2024 - Global X
3 Gene Editing Stocks With Unprecedented Surge Potential - InvestorPlace
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential - InvestorPlace
The Next Big Theme: January 2024 - Global X
Two industries where Einstein would invest - Finimize
3 Biotech ETFs to Bet on Now - Nasdaq
M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024 - InvestorPlace
Global X Genomics Biotechnology Etf Stock (GNOM) Financials Data
There is no financial data for Global X Genomics Biotechnology Etf (GNOM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.36%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):